197 related articles for article (PubMed ID: 3778712)
1. Fracture healing with deferoxamine therapy in a patient with aluminum-associated osteomalacia.
Phelps KR; Einhorn TA; Vigorita VJ; Lundin AP; Friedman EA
ASAIO Trans; 1986; 32(1):198-200. PubMed ID: 3778712
[No Abstract] [Full Text] [Related]
2. Clinical and biochemical features of aluminum-related bone disease.
Ihle BU; Becker GJ; Kincaid-Smith PS
Kidney Int Suppl; 1986 Feb; 18():S80-6. PubMed ID: 3458003
[No Abstract] [Full Text] [Related]
3. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW
Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
[No Abstract] [Full Text] [Related]
4. Aluminum intoxication of bone in renal failure--fact or fiction?
Malluche HH; Faugere MC; Smith AJ; Friedler RM
Kidney Int Suppl; 1986 Feb; 18():S70-3. PubMed ID: 3458000
[No Abstract] [Full Text] [Related]
5. Changes in bone histology after treatment with desferrioxamine.
Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ
Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
[No Abstract] [Full Text] [Related]
6. Osteomalacia and bone disease arising from aluminum.
Coburn JW; Norris KC; Nebeker HG
Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
[No Abstract] [Full Text] [Related]
7. Bilateral sequential tibial and fibular fatigue fractures associated with aluminum intoxication osteomalacia. A case report.
Skinner HB; Harris JR; Cook SD; O'Neill WM
J Bone Joint Surg Am; 1983 Jul; 65(6):843-7. PubMed ID: 6863369
[No Abstract] [Full Text] [Related]
8. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
Nebeker HG; Andress DL; Milliner DS; Ott SM; Alfrey AC; Slatopolsky EA; Sherrard DJ; Coburn JW
Kidney Int Suppl; 1986 Feb; 18():S96-9. PubMed ID: 3458006
[No Abstract] [Full Text] [Related]
9. [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
Charhon SA; Chavassieux P; Chapuy MC; Accominotti M; Traeger J; Meunier PJ
Presse Med; 1986 Jan; 15(2):55-9. PubMed ID: 2935857
[TBL] [Abstract][Full Text] [Related]
10. [Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine].
Espinoza O; Gehrung E; Roessler E; Katz E; Pérez A; Delmastro J
Rev Med Chil; 1986 Sep; 114(9):867-71. PubMed ID: 3575972
[No Abstract] [Full Text] [Related]
11. Therapy of aluminum overload (I).
Pierides AM; Myli MP
Contrib Nephrol; 1984; 38():65-77. PubMed ID: 6425013
[No Abstract] [Full Text] [Related]
12. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM
Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
[TBL] [Abstract][Full Text] [Related]
13. Aluminum-related osteomalacia in renal-failure patients.
Vick KE; Johnson CA
Clin Pharm; 1985; 4(4):434-9. PubMed ID: 3899471
[TBL] [Abstract][Full Text] [Related]
14. Therapy of aluminium overload (II).
Ackrill P; Day JP
Contrib Nephrol; 1984; 38():78-80. PubMed ID: 6713902
[No Abstract] [Full Text] [Related]
15. [Toxic effect of aluminum in chronic renal failure].
Głuszek J
Pol Tyg Lek; 1987 Nov; 42(48):1499-502. PubMed ID: 3451199
[No Abstract] [Full Text] [Related]
16. Aluminum and renal bone disease in Australia.
Dunstan CR; Evans RA
Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
[No Abstract] [Full Text] [Related]
17. [Aluminum-induced osteomalacia in chronic hemodialysis].
Smetana S; Popovtzer MM; Bar-Khayim Y
Harefuah; 1987 Jun; 112(12):595-7. PubMed ID: 3428727
[No Abstract] [Full Text] [Related]
18. The interaction of parathyroid hormone and aluminum in renal osteodystrophy.
Slatopolsky E
Kidney Int; 1987 Mar; 31(3):842-54. PubMed ID: 3573543
[No Abstract] [Full Text] [Related]
19. Aluminum-induced dialysis osteodystrophy: the demise of "Newcastle bone disease"?
Kerr DN; Ward MK; Arze RS; Ramos JM; Grekas D; Parkinson IS; Ellis HA; Owen JP; Simpson W; Dewar J
Kidney Int Suppl; 1986 Feb; 18():S58-64. PubMed ID: 3457998
[No Abstract] [Full Text] [Related]
20. Treatment of fracturing renal osteodystrophy by desferrioxamine.
Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
